SG11201705728RA - Methods of treating inflammatory diseases - Google Patents
Methods of treating inflammatory diseasesInfo
- Publication number
- SG11201705728RA SG11201705728RA SG11201705728RA SG11201705728RA SG11201705728RA SG 11201705728R A SG11201705728R A SG 11201705728RA SG 11201705728R A SG11201705728R A SG 11201705728RA SG 11201705728R A SG11201705728R A SG 11201705728RA SG 11201705728R A SG11201705728R A SG 11201705728RA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- inflammatory diseases
- treating inflammatory
- treating
- diseases
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562111731P | 2015-02-04 | 2015-02-04 | |
| US201562130876P | 2015-03-10 | 2015-03-10 | |
| US201562135335P | 2015-03-19 | 2015-03-19 | |
| US201562145764P | 2015-04-10 | 2015-04-10 | |
| US201562204520P | 2015-08-13 | 2015-08-13 | |
| US201562235631P | 2015-10-01 | 2015-10-01 | |
| PCT/US2016/016061 WO2016126638A1 (en) | 2015-02-04 | 2016-02-02 | Methods of treating inflammatory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201705728RA true SG11201705728RA (en) | 2017-08-30 |
Family
ID=55453266
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201705728RA SG11201705728RA (en) | 2015-02-04 | 2016-02-02 | Methods of treating inflammatory diseases |
| SG10202103879YA SG10202103879YA (en) | 2015-02-04 | 2016-02-02 | Methods of treating inflammatory diseases |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202103879YA SG10202103879YA (en) | 2015-02-04 | 2016-02-02 | Methods of treating inflammatory diseases |
Country Status (15)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20141162A1 (es) | 2010-11-04 | 2014-09-18 | Boehringer Ingelheim Int | Anticuerpos anti-il-23 |
| CN104507497B (zh) | 2012-05-03 | 2018-10-19 | 勃林格殷格翰国际有限公司 | 抗IL-23p19抗体 |
| WO2016014775A1 (en) | 2014-07-24 | 2016-01-28 | Boehringer Ingelheim International Gmbh | Biomarkers useful in the treatment of il-23a related diseases |
| KR102523914B1 (ko) | 2014-09-03 | 2023-04-19 | 베링거잉겔하임인터내쇼날유한회사 | Il-23a 및 tnf-알파를 표적으로 하는 화합물 및 이의 용도 |
| CN107206081A (zh) * | 2015-02-04 | 2017-09-26 | 勃林格殷格翰国际有限公司 | 治疗炎性疾病的方法 |
| EP3560956A3 (en) * | 2016-04-15 | 2020-01-01 | Boehringer Ingelheim International GmbH | Methods of treating inflammatory diseases |
| AU2017336799B2 (en) * | 2016-09-30 | 2023-08-31 | Janssen Biotech, Inc. | Safe and effective method of treating psoriasis with anti-IL23 specific antibody |
| CN106778030B (zh) * | 2017-01-10 | 2023-04-07 | 广州和康医疗技术有限公司 | 一种强直性脊柱炎病情监测管理系统及其监测管理方法 |
| MA55149A (fr) | 2018-11-20 | 2021-09-29 | Janssen Biotech Inc | Procédé sûr et efficace de traitement du psoriasis avec un anticorps spécifique anti-il-23 |
| CN111378045B (zh) | 2018-12-28 | 2022-08-02 | 长春金赛药业有限责任公司 | 二价双特异性抗体及其制备方法、编码基因、宿主细胞、组合物 |
| TW202123965A (zh) * | 2019-09-09 | 2021-07-01 | 德商百靈佳殷格翰國際股份有限公司 | 抗-il-23p19抗體調配物 |
| JP2025503948A (ja) * | 2022-01-25 | 2025-02-06 | サン ファーマシューティカル インダストリーズ リミテッド | 頭皮の尋常性乾癬を有する対象者の治療方法 |
| WO2025051249A1 (zh) * | 2023-09-07 | 2025-03-13 | 信达生物制药(苏州)有限公司 | 一种重组抗IL-23p19抗体治疗中重度银屑病的方法 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
| NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
| US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
| US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| ATE135397T1 (de) | 1988-09-23 | 1996-03-15 | Cetus Oncology Corp | Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte |
| FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
| EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| ATE255131T1 (de) | 1991-06-14 | 2003-12-15 | Genentech Inc | Humanisierter heregulin antikörper |
| ES2152483T3 (es) | 1992-11-13 | 2001-02-01 | Idec Pharma Corp | Aplicacion terapeutica en anticuerpos quimericos y radiomarcados contra el antigeno de diferenciacion restringida de los linfocitos b humanos para el tratamiento del linfoma de celulas b. |
| US6037454A (en) | 1996-11-27 | 2000-03-14 | Genentech, Inc. | Humanized anti-CD11a antibodies |
| JP2009501006A (ja) | 2005-06-30 | 2009-01-15 | セントカー・インコーポレーテツド | 抗ｉｌ−２３抗体、組成物、方法および用途 |
| PL1937721T3 (pl) | 2005-08-25 | 2010-12-31 | Lilly Co Eli | Przeciwciała anty-IL23 |
| DK1931710T3 (en) | 2005-08-31 | 2017-04-03 | Merck Sharp & Dohme | CONSTRUCTED ANTI-IL-23 ANTIBODIES |
| EP1971366B1 (en) | 2005-12-29 | 2014-07-30 | Janssen Biotech, Inc. | Human anti-il-23 antibodies, compositions, methods and uses |
| MX2009009079A (es) | 2007-02-23 | 2009-08-31 | Schering Corp | Anticuerpos anti-il-23p19 de ingenieria. |
| PE20141162A1 (es) * | 2010-11-04 | 2014-09-18 | Boehringer Ingelheim Int | Anticuerpos anti-il-23 |
| CN104507497B (zh) * | 2012-05-03 | 2018-10-19 | 勃林格殷格翰国际有限公司 | 抗IL-23p19抗体 |
| ES2729603T3 (es) * | 2012-06-27 | 2019-11-05 | Merck Sharp & Dohme | Anticuerpos IL-23 antihumanos cristalinos |
| CA2906382A1 (en) * | 2013-03-15 | 2014-09-25 | Amgen Inc. | Methods for treating psoriasis using an anti-il-23 antibody |
| CN107206081A (zh) | 2015-02-04 | 2017-09-26 | 勃林格殷格翰国际有限公司 | 治疗炎性疾病的方法 |
| JP7090014B2 (ja) * | 2018-11-07 | 2022-06-23 | 株式会社ミツバ | ロータ、モータ、ブラシレスワイパーモータ及びロータの製造方法 |
-
2016
- 2016-02-02 CN CN201680008402.3A patent/CN107206081A/zh active Pending
- 2016-02-02 IL IL307578A patent/IL307578A/en unknown
- 2016-02-02 US US15/013,008 patent/US20160222102A1/en active Pending
- 2016-02-02 CA CA2972995A patent/CA2972995A1/en active Pending
- 2016-02-02 SG SG11201705728RA patent/SG11201705728RA/en unknown
- 2016-02-02 CN CN202110769475.7A patent/CN113559258A/zh active Pending
- 2016-02-02 AU AU2016215535A patent/AU2016215535B2/en active Active
- 2016-02-02 KR KR1020247035213A patent/KR20240158362A/ko active Pending
- 2016-02-02 BR BR112017014684A patent/BR112017014684A2/pt not_active Application Discontinuation
- 2016-02-02 WO PCT/US2016/016061 patent/WO2016126638A1/en not_active Application Discontinuation
- 2016-02-02 MX MX2017010037A patent/MX392789B/es unknown
- 2016-02-02 JP JP2017541030A patent/JP6758304B2/ja active Active
- 2016-02-02 EP EP16707997.9A patent/EP3253794A1/en active Pending
- 2016-02-02 EA EA201791734A patent/EA201791734A1/ru unknown
- 2016-02-02 KR KR1020177024896A patent/KR20170120616A/ko not_active Ceased
- 2016-02-02 SG SG10202103879YA patent/SG10202103879YA/en unknown
-
2017
- 2017-06-22 IL IL253118A patent/IL253118A0/en unknown
- 2017-08-01 CL CL2017001960A patent/CL2017001960A1/es unknown
- 2017-08-01 PH PH12017501378A patent/PH12017501378A1/en unknown
- 2017-08-03 MX MX2022006575A patent/MX2022006575A/es unknown
- 2017-08-03 MX MX2022006573A patent/MX2022006573A/es unknown
-
2020
- 2020-04-27 JP JP2020078179A patent/JP7042298B2/ja active Active
- 2020-04-27 JP JP2020078177A patent/JP7044824B2/ja active Active
- 2020-04-27 JP JP2020078178A patent/JP7042297B2/ja active Active
-
2021
- 2021-12-16 AU AU2021286378A patent/AU2021286378B2/en active Active
-
2022
- 2022-03-17 JP JP2022042417A patent/JP2022081644A/ja active Pending
-
2024
- 2024-12-24 JP JP2024227224A patent/JP2025060798A/ja active Pending
- 2024-12-24 JP JP2024227221A patent/JP2025060797A/ja active Pending
-
2025
- 2025-06-10 AU AU2025204286A patent/AU2025204286A1/en active Pending
- 2025-06-26 IL IL321788A patent/IL321788A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL266770A (en) | Methods for treating inflammatory conditions | |
| IL321788A (en) | Methods for treating inflammatory diseases | |
| IL285151B1 (en) | Methods for the treatment of fgf21-related disorders | |
| IL257561A (en) | Methods for treating inflammatory diseases | |
| IL253244A0 (en) | Methods for treating retinal diseases | |
| GB201701673D0 (en) | Methods of well treatment | |
| PT3169328T (pt) | Derivados de quinolina para o tratamento de doenças inflamatórias | |
| ZA201706059B (en) | Method of treatment with tradipitant | |
| IL252296A0 (en) | Methods for treating multiple sclerosis | |
| IL249098A0 (en) | Methods and preparations for the treatment of allergy and inflammatory diseases | |
| ZA201705877B (en) | Method of treating diseases | |
| IL256207B (en) | Methods for treating multiple sclerosis | |
| IL257764B (en) | Methods for treatment of diseases | |
| GB201416832D0 (en) | Methods of treatment | |
| SG11201708181RA (en) | Methods for the treatment of inflammatory disorders | |
| IL254825A0 (en) | Methods of treatment with Tesalisib | |
| IL253847A0 (en) | Methods of treating diseases | |
| HUE063820T2 (hu) | Módszerek kardiovaszkuláris betegségek kezelésére | |
| GB201515244D0 (en) | Treatment of inflammatory disease or condition | |
| IL252707B (en) | Compositions and methods for treating diseases | |
| GB201512139D0 (en) | Methods of treatment | |
| HK1240245A1 (en) | Methods of treating inflammatory diseases | |
| HK40015138A (en) | Methods of treating inflammatory conditions | |
| ZA201704724B (en) | Peptide for treating inflammatory diseases | |
| GB201516418D0 (en) | Treatment of acute inflammatory disorders |